Growth Metrics

Bioventus (BVS) Depreciation & Amortization (CF) (2020 - 2026)

Bioventus filings provide 6 years of Depreciation & Amortization (CF) readings, the most recent being $11.7 million for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 5.73% to $11.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $47.0 million, a 5.13% decrease, with the full-year FY2025 number at $47.0 million, down 5.13% from a year prior.
  • Depreciation & Amortization (CF) hit $11.7 million in Q4 2025 for Bioventus, up from $11.4 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $16.9 million in Q4 2022 to a low of $7.2 million in Q2 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $12.3 million (2022), compared with a mean of $12.2 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 73.71% in 2022 and later fell 28.46% in 2024.
  • Bioventus' Depreciation & Amortization (CF) stood at $11.7 million in 2021, then surged by 44.93% to $16.9 million in 2022, then fell by 26.43% to $12.5 million in 2023, then dropped by 0.48% to $12.4 million in 2024, then dropped by 5.73% to $11.7 million in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $11.7 million (Q4 2025), $11.4 million (Q3 2025), and $12.0 million (Q2 2025) per Business Quant data.